ALR Related Analyst EPS View
-
Wedbush Downgrades Alere (ALR) to Neutral, Cities Poor Risk/Reward
-
Jefferies Maintains a 'Buy' on Alere (ALR); Taking the Good with the Bad
-
UPDATE: Canaccord Genuity Downgrades Meridian Biosciences (VIVO) to Hold; Changing Investment Thesis
-
Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles
-
Canaccord Genuity Maintains a 'Buy' on Alere (ALR); Q2 Preview: Looking for Clarity
-
Leerink Swann Downgrades Alere (ALR) to Market Perform
-
Leerink Swann Upgrades Alere (ALR) to Outperform; Clean Beat, Continued Upside Potential
Back to ALR Stock Lookup
